Paper29556361
Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide.
Vandergriff A and 7 others. Theranostics, 2018. Cited by 338 papers, by iCite.
Cite this record
ConductScience Library. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Papers, record 29556361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29556361
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Biological Therapy | Major topic |
| Exosomes | Major topic |
| Molecular Targeted Therapy | Major topic |
| Myocardial Infarction | Major topic |
| Peptides | Major topic |
| Administration, Intravenous | |
| Animals | |
| Cell Survival | |
| Disease Models, Animal | |
| Echocardiography | |
| Myocytes, Cardiac | |
| Rats | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01HL123920 | NIH | NIH RePORTER | |||
| R01HL137093 | NIH | NIH RePORTER |
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24231649 | Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. | Nat Commun | 2013 | https://conductscience.org/library/papers/24231649 | PubMed |
| 2 | 22088800 | Retracted: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. | Lancet | 2011 | https://conductscience.org/library/papers/22088800 | PubMed |
| 3 | 22959595 | Exosomes for drug delivery - a novel application for the mesenchymal stem cell. | Biotechnol Adv | 2013 | https://conductscience.org/library/papers/22959595 | PubMed |
| 4 | 22666372 | Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. | PLoS One | 2012 | https://conductscience.org/library/papers/22666372 | PubMed |
| 5 | 20404348 | MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20404348 | PubMed |
| 6 | 16308420 | The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. | Science | 2005 | https://conductscience.org/library/papers/16308420 | PubMed |
| 7 | 27213331 | Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27213331 | PubMed |
| 8 | 23583246 | Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23583246 | PubMed |
| 9 | 23562828 | Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. | J Biotechnol | 2013 | https://conductscience.org/library/papers/23562828 | PubMed |
| 10 | 28045024 | Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. | Nat Commun | 2017 | https://conductscience.org/library/papers/28045024 | PubMed |
| 11 | 22059153 | Extracellular/circulating microRNAs and their potential role in cardiovascular disease. | Am J Cardiovasc Dis | 2011 | https://conductscience.org/library/papers/22059153 | PubMed |
| 12 | 23208587 | Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. | Cardiovasc Res | 2013 | https://conductscience.org/library/papers/23208587 | PubMed |
| 13 | 25534971 | Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation. | Stem Cells | 2015 | https://conductscience.org/library/papers/25534971 | PubMed |
| 14 | 24468403 | The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. | Biomaterials | 2014 | https://conductscience.org/library/papers/24468403 | PubMed |
| 15 | 17612493 | MicroRNA targeting specificity in mammals: determinants beyond seed pairing. | Mol Cell | 2007 | https://conductscience.org/library/papers/17612493 | PubMed |
| 16 | 19346324 | Globally optimal stitching of tiled 3D microscopic image acquisitions. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19346324 | PubMed |
| 17 | 16242455 | Increasing transplanted cell survival with cell-based angiogenic gene therapy. | Ann Thorac Surg | 2005 | https://conductscience.org/library/papers/16242455 | PubMed |
| 18 | 29862136 | Targeted repair of heart injury by stem cells fused with platelet nanovesicles. | Nat Biomed Eng | 2018 | https://conductscience.org/library/papers/29862136 | PubMed |
| 19 | 25344555 | Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. | Circ Res | 2015 | https://conductscience.org/library/papers/25344555 | PubMed |
| 20 | 23104321 | Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23104321 | PubMed |
Cited by255
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 338 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42992394 | Disease-Specific Determinants of Cardiovascular Nanomedicine: Mechanisms, Limitations, and Translational Opportunities. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42992394 | PubMed |
| 42964572 | Novel modifications of small extracellular vesicles to enhance cardiac-specific delivery of siPKA RNA and edaravone against ischemia-reperfusion cardiac injury. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42964572 | PubMed |
| 42891147 | Region-specific human cardiac extracellular vesicles differentially regulate mitochondrial function. | Extracell Vesicles Circ Nucl Acids | 2026 | https://conductscience.org/library/papers/42891147 | PubMed |
| 42747705 | Extracellular vesicles in targeted drug delivery: from biological functions to surface engineering. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42747705 | PubMed |
| 42717123 | The Role and Mechanism of Endothelial Progenitor Cell-Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease. | J Cardiovasc Transl Res | 2026 | https://conductscience.org/library/papers/42717123 | PubMed |
| 42665772 | Nano-enabled natriuretic peptide therapy in post-myocardial infarction heart failure: from functional NP deficiency to dual-axis (cGMP-dependent and -independent) cardioprotection. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42665772 | PubMed |
| 42645300 | Biomaterial-Assisted Stem Cell Therapy and Exosome Delivery in Myocardial Infarction: A Narrative Review. | Biomimetics (Basel) | 2026 | https://conductscience.org/library/papers/42645300 | PubMed |
| 42637892 | NADPH oxidases in immunometabolism and disease pathology: mechanistic networks, pollutant triggers, and therapeutic frontiers. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42637892 | PubMed |
| 42601955 | Extracellular vesicles in heart failure: bridging pathogenic insights, diagnostic utility, and therapeutic applications. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42601955 | PubMed |
| 42505044 | Engineered exosomes improve myocardial cell membrane integrity and heart function in dystrophic cardiomyopathy. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42505044 | PubMed |
| 42488359 | MicroRNAs won the Nobel Prize. Now, can extracellular vesicles help them become drugs? | Extracell Vesicle | 2025 | https://conductscience.org/library/papers/42488359 | PubMed |
| 42418057 | Bench to Bedside: Insights from Large Animal Models and Emerging Clinical Trials of Endogenous Cardiac Regeneration and Repair. | J Cardiovasc Transl Res | 2026 | https://conductscience.org/library/papers/42418057 | PubMed |
| 42395877 | Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42395877 | PubMed |
| 42357313 | Cell-Specific Extracellular Vesicles Targeting Strategies for Immune Modulation in Inflammatory Diseases. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357313 | PubMed |
| 42337937 | Engineering Extracellular Vesicles for Anti-Aging Therapy: Mechanisms, Applications, and Perspectives. | Aging Cell | 2026 | https://conductscience.org/library/papers/42337937 | PubMed |
| 42323526 | Extracellular vesicle-mediated mechanisms and therapeutic potential in acute lung injury. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42323526 | PubMed |
| 42131476 | N-Amino Peptide-Graphene Quantum Dot Loaded Small Extracellular Vesicles for Targeted Therapy of Tauopathies. | Adv Nanobiomed Res | 2025 | https://conductscience.org/library/papers/42131476 | PubMed |
| 42086976 | Engineered ATP-loaded extracellular vesicles: a dual-functional strategy for improving myocardial infarction therapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42086976 | PubMed |
| 42041524 | Stem Cells and Their Derivatives in Cardiac Fibrosis Therapy: Challenges and Perspectives. | Cells | 2026 | https://conductscience.org/library/papers/42041524 | PubMed |
| 42037316 | Biomimetic Bone Marrow Monocyte Membrane-Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42037316 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VWF | 7450 | PubTator's text mining | https://conductscience.org/library/genes/7450 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29556361
GET https://conductscience.org/api/papers/v1/29556361/references?page=2